Chuang, S.-T.; Papp, H.; Kuczmog, A.; Eells, R.; Condor Capcha, J.M.; Shehadeh, L.A.; Jakab, F.; Buchwald, P.
Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19. Pharmaceuticals 2022, 15, 621.
https://doi.org/10.3390/ph15050621
AMA Style
Chuang S-T, Papp H, Kuczmog A, Eells R, Condor Capcha JM, Shehadeh LA, Jakab F, Buchwald P.
Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19. Pharmaceuticals. 2022; 15(5):621.
https://doi.org/10.3390/ph15050621
Chicago/Turabian Style
Chuang, Sung-Ting, Henrietta Papp, Anett Kuczmog, Rebecca Eells, Jose M. Condor Capcha, Lina A. Shehadeh, Ferenc Jakab, and Peter Buchwald.
2022. "Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19" Pharmaceuticals 15, no. 5: 621.
https://doi.org/10.3390/ph15050621
APA Style
Chuang, S. -T., Papp, H., Kuczmog, A., Eells, R., Condor Capcha, J. M., Shehadeh, L. A., Jakab, F., & Buchwald, P.
(2022). Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19. Pharmaceuticals, 15(5), 621.
https://doi.org/10.3390/ph15050621